We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Officials, Neuroscience Committee Face Off Over Aduhelm in Dueling NEJM Editorials
FDA Officials, Neuroscience Committee Face Off Over Aduhelm in Dueling NEJM Editorials
Seven members of the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee are knocking heads with FDA officials over Aduhelm with sparring editorials published in the New England Journal of Medicine.